Vical Incorporated (NASDAQ:VICL)

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor.

VICL and Astellas Pharma Inc. have signed exclusive license agreements to develop and commercialize globally TransVax, Vical's therapeutic vaccine designed to control cytomegalovirus reactivation in transplant recipients.

To view video click here http://crweselect.com/24866/stock-alerts/vicl-mrcy-jbht-crweselectcom-st...

Vical potentially may receive up to $130 million in total upfront and milestone payments through commercial launch and double-digit royalties on net sales.

"Our first-in-class CMV vaccine would complement the existing Astellas franchise in the transplant market, a strategic focus area for Astellas. This program will bring together Astellas' substantial resources and strong commercial presence in key world markets, and Vical's development, regulatory and manufacturing expertise with DNA-based product candidates," stated Vijay Samant, President and Chief Executive Officer of Vical.

Under the agreements, Astellas will be responsible for further development and commercialization, including all costs. Vical has an option to co-promote TransVax(TM) in the United States. Vical will provide assistance to Astellas with TransVax(TM)-related manufacturing, regulatory and certain development activities, for which Astellas will reimburse all of Vical's future costs, including personnel and external expenses. Vical will receive near-term payments of $35 million, including $25 million upon the effective date and $10 million upon finalization of the Phase 3 trial design.

For more information about Vical Incorporated please visit http://www.vical.com/

****

Mercury Computer Systems, Inc. (NASDAQ:MRCY)

Mercury Computer Systems is a best of breed provider of open, commercially developed, application-ready, multi-INT subsystems for the ISR market. With over 30 years of experience in embedded computing, superior domain expertise in radar, EW, EO/IR, C4I, and sonar applications, and more than 300 successful program deployments including Aegis, Global Hawk, and Predator, Mercury’s Services and Systems Integration team leads the industry in partnering with customers to design and integrate system-level solutions that minimize program risk, maximize application portability, and accelerate customers’ time to market.

MRCY confirmed that it has been awarded a contract from a global supplier of advanced communication and navigation solutions for an advanced signal and image processing engine.

“This long-standing customer knows it can rely on Mercury to provide the technology needed to migrate an existing radar system from a closed, proprietary design to an open system with built-in application portability,” stated Didier Thibaud, senior vice president and general manager of Mercury Computer Systems’ Advanced Computing Solutions business unit.

For more information about Mercury Computer Systems, Inc. please visit http://www.mc.com/

****

JB Hunt Transport Services, Inc. (NASDAQ:JBHT)

JB Hunt Transport Services, Inc., one of the largest transportation logistics companies in North America, provides safe and reliable transportation services to a diverse group of customers throughout the continental United States, Canada and Mexico. Utilizing an integrated, multimodal approach, JB Hunt Transport Services provides capacity-oriented solutions centered on delivering customer value and industry-leading service.

JBHT reported record revenues and record earnings for the Second Quarter 2011, with revenue of $1.15 billion dollars, a 22% increase year-over-year and net earnings of $65.7 million, a 26% increase over the prior year.

“The second quarter of 2011 yielded record revenues and record earnings. We attribute the accomplishments to the intelligence and hard work of our people who make it happen every day, every stop, and every mile. Intermodal and DCS, which make up over 80% of the Company’s total revenue, continued to demonstrate the differentiation qualities we have been working to highlight for some time. Both of these businesses have established a leadership position in their respective fields of service. During lingering economic pressures and unsteadiness in the general freight markets, JBI and DCS once again revealed a higher degree of resiliency than that of traditional, full truckload transportation models. Additionally, we realized year-over-year improvement in ICS despite continued pressure on margins created from the lackluster macroeconomic environment,” stated John N. Roberts, JBHT President and CEO.

For more information about JB Hunt Transport Services, Inc. please visit http://www.jbhunt.com/

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.

Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

VICLcrweselect0714
JBHTcrweselect0714
MRCYcrweselect0714